Inventor · disambiguated record
Harish Ravivarapu
Also filed as: RAVIVARAPU HARISH
8 granted patents·6 pending applications·486 citations·filing 2000–2020
89Inventor score
Files withASTEX PHARMACEUTICALS INC3ATRIX LAB INC3DUNN RICHARD L2TOLMAR THERAPEUTICS INC2DENALI THERAPEUTICS INC1
Top patents by PatentIndex Score
14 records- 0198US6773714B2Polymeric delivery formulations of leuprolide with improved efficacyATRIX LAB INC·Filed 2003·Granted Aug 10, 2004·224 cites·47 claims
- 0298US6565874B1Polymeric delivery formulations of leuprolide with improved efficacyATRIX LAB INC·Filed 2000·Granted May 20, 2003·214 cites·49 claims
- 0395US8486455B2Polymeric delivery formulations of leuprolide with improved efficacyDUNN RICHARD L·Filed 2010·Granted Jul 16, 2013·25 cites·5 claims
- 0487US9913856B2Drug formulationsASTEX PHARMACEUTICALS INC·Filed 2016·Granted Mar 13, 2018·6 cites·14 claims
- 0586US9254307B2Polymeric delivery formulations of leuprolide with improved efficacyDUNN RICHARD L·Filed 2010·Granted Feb 9, 2016·6 cites·3 claims
- 0683US9381207B2Drug formulationsJOSHI-HANGAL RAJASHREE·Filed 2012·Granted Jul 5, 2016·9 cites·40 claims
- 0780US10517886B2Drug formulationsASTEX PHARMACEUTICALS INC·Filed 2018·Granted Dec 31, 2019·2 cites·12 claims
- 0875US11058705B2Drug formulationsASTEX PHARMACEUTICALS INC·Filed 2019·Granted Jul 13, 2021·0 cites·19 claims
- 0961US2007104759A1Polymeric delivery formulations of leuprolide with improved efficacyQLT USA INC·Filed 2006·Application pending·0 cites
- 1059US2004229912A1Polymeric delivery formulations of leuprolide with improved efficacyATRIX LAB INC·Filed 2004·Application pending·0 cites
- 1158US2016106805A1Polymeric delivery formulations of leuprolide with improved efficacyTOLMAR THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1256US2015150937A1Polymeric delivery formulations of leuprolide with improved efficacyTOLMAR THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1352US2022249479A1Modified release formulation of a pyrimidinylamino-pyrazole compound, and methods of treatmentDENALI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1452US2004162263A1Pharmaceutical formulations targeting specific regions of the gastrointesinal tractSUPERGEN INC A DELAWARE CORP·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →